share_log

HC Wainwright & Co. Reiterates Buy on Allogene Therapeutics, Maintains $23 Price Target

HC Wainwright & Co. Reiterates Buy on Allogene Therapeutics, Maintains $23 Price Target

HC Wainwright & Co.重申买入Allogene Therapeutics,维持23美元的目标股价
Benzinga ·  2023/08/07 06:21

HC Wainwright & Co. analyst Robert Burns reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $23 price target.

HC Wainwright & Co. 分析师罗伯特·伯恩斯重申Allogene Therapeutics(纳斯达克股票代码:ALLO)的买入并维持23美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发